Regeneron Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/9/2026 | 316 | 0.0% | 410 | 12/31/2025 |
| 2025 Q3 | 10/10/2025 | 463 | 0.0% | 823 | 9/30/2025 |
| 2025 Q2 | 8/12/2025 | 535 | 0.0% | 1,019 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 952 | 0.0% | 1,501 | 3/31/2025 |
| 2024 Q4 | 2/5/2025 | 5,337 | 0.1% | 7,493 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 21,143 | 0.4% | 20,112 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 22,917 | 0.4% | 21,805 | 6/30/2024 |
| 2024 Q1 | 5/3/2024 | 18,771 | 0.4% | 19,502 | 3/31/2024 |
| 2023 Q4 | 1/30/2024 | 16,547 | 0.4% | 18,840 | 12/31/2023 |
| 2023 Q3 | 11/6/2023 | 15,433 | 0.4% | 18,753 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 13,257 | 0.4% | 18,450 | 6/30/2023 |
| 2023 Q1 | 4/27/2023 | 15,241 | 0.5% | 18,549 | 3/31/2023 |
| 2022 Q4 | 1/31/2023 | 13,378 | 0.5% | 18,543 | 12/31/2022 |
| 2022 Q3 | 11/7/2022 | 12,793 | 0.5% | 18,571 | 9/30/2022 |
| 2022 Q2 | 8/8/2022 | 10,781 | 0.4% | 18,238 | 6/30/2022 |
| 2022 Q1 | 4/28/2022 | 12,631 | 0.4% | 18,085 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 11,957 | 0.4% | 18,934 | 12/31/2021 |
| 2021 Q3 | 10/26/2021 | 11,512 | 0.4% | 19,023 | 9/30/2021 |
| 2021 Q2 | 8/11/2021 | 10,367 | 0.4% | 18,561 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 8,557 | 0.4% | 18,086 | 3/31/2021 |
| 2020 Q4 | 2/2/2021 | 9,201 | 0.4% | 19,044 | 12/31/2020 |
| 2020 Q3 | 11/3/2020 | 10,077 | 0.6% | 18,002 | 9/30/2020 |
| 2020 Q2 | 8/13/2020 | 11,922 | 0.7% | 19,117 | 6/30/2020 |
| 2020 Q1 | 5/8/2020 | 8,836 | 0.7% | 18,096 | 3/31/2020 |
| 2019 Q4 | 1/30/2020 | 6,235 | 0.4% | 16,607 | 12/31/2019 |